Deutsche Bank Maintains a 'Buy' on Medicis (MRX) After In-Depth Meeting with Management

Deutsche Bank maintains a 'Buy' on Medicis (NYSE: MRX) price target raised from $41 to $44.

Analyst, David M Steinberg, said, "On Tuesday, we hosted an in-depth meeting with Medicis management which included a detailed look at the company’s key marketed products, development pipeline, business development activities, and growth outlook. Given our positive bias post this company visit, in tandem with positive momentum on the recent Zyclara launch, we continue to rate Medicis shares Buy."

For an analyst ratings summary and ratings history on Medicis click here. For more ratings news on Medicis click here.

Shares of Medicis closed at $38.23 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rentokil Initial (RTO) PT Lowered to $35 at Oppenheimer
• Boston Beer Company (SAM) PT Lowered to $310 at Evercore ISI
• Infosys Technologies (INFY) PT Lowered to $18 at BMO Capital